Adiponectin induced AMP-activated protein kinase impairment mediates insulin resistance in Bama mini-pig fed high-fat and high-sucrose diet
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: Adipose tissue is no longer considered as an inert storage organ for lipid, but instead is thought to play an active role in regulating insulin effects via secretion adipokines. However, conflicting reports have emerged regarding the effects of adipokines. In this study, we investigated the role of adipokines in glucose metabolism and insulin sensitivity in obese Bama mini-pigs. Methods: An obesity model was established in Bama mini-pigs, by feeding with high-fat and high-sucrose diet for 30 weeks. Plasma glucose and blood biochemistry levels were measured, and intravenous glucose tolerance test was performed. Adipokines, including adiponectin, interleukin-6 (IL-6), resistin and tumor necrosis factor alpha (TNF-α), and glucose-induced insulin secretion were also examined by radioimmunoassay. AMP-activated protein kinase (AMPK) phosphorylation in skeletal muscle, which is a useful insulin resistance marker, was examined by immunoblotting. Additionally, associations of AMPK phosphorylation with plasma adipokines and homeostasis model assessment of insulin resistance (HOMA-IR) index were assessed by Pearce's correlation analysis. Results: Obese pigs showed hyperglycemia, high triglycerides, and insulin resistance. Adiponectin levels were significantly decreased (p<0.05) and IL-6 amounts dramatically increased (p<0.05) in obese pigs both in serum and adipose tissue, corroborating data from obese mice and humans. However, circulating resistin and TNF-α showed no difference, while the values of TNF-α in adipose tissue were significantly higher in obese pigs, also in agreement with data from obese humans but not rodent models. Moreover, strong associations of skeletal muscle AMPK phosphorylation with plasma adiponectin and HOMA-IR index were obtained. Conclusion: AMPK impairment induced by adiponectin decrease mediates insulin resistance in high-fat and high-sucrose diet induction. In addition, Bama mini-pig has the possibility of a conformable model for human metabolic diseases.
Abstract
Objective: Adipose tissue is no longer considered as an inert storage organ for lipid, but instead is thought to play an active role in regulating insulin effects via secretion adipokines. However, conflicting reports have emerged regarding the effects of adipokines. In this study, we investigated the role of adipokines in glucose metabolism and insulin sensitivity in obese Bama mini-pigs. Methods: An obesity model was established in Bama mini-pigs, by feeding with high-fat and high-sucrose diet for 30 weeks. Plasma glucose and blood biochemistry levels were measured, and intravenous glucose tolerance test was performed. Adipokines, including adiponectin, interleukin-6 (IL-6), resistin and tumor necrosis factor alpha (TNF-α), and glucose-induced insulin secretion were also examined by radioimmunoassay. AMP-activated protein kinase (AMPK) phosphorylation in skeletal muscle, which is a useful insulin resistance marker, was examined by immunoblotting. Additionally, associations of AMPK phosphorylation with plasma adipokines and homeostasis model assessment of insulin resistance (HOMA-IR) index were assessed by Pearce's correlation analysis. Results: Obese pigs showed hyperglycemia, high triglycerides, and insulin resistance. Adiponectin levels were significantly decreased (p<0.05) and IL-6 amounts dramatically increased (p<0.05) in obese pigs both in serum and adipose tissue, corroborating data from obese mice and humans. However, circulating resistin and TNF-α showed no difference, while the values of TNF-α in adipose tissue were significantly higher in obese pigs, also in agreement with data from obese humans but not rodent models. Moreover, strong associations of skeletal muscle AMPK phosphorylation with plasma adiponectin and HOMA-IR index were obtained. Conclusion: AMPK impairment induced by adiponectin decrease mediates insulin resistance in high-fat and high-sucrose diet induction. In addition, Bama mini-pig has the possibility of a conformable model for human metabolic diseases.
참고문헌 (40)
- Cois A, "Obesity trends and risk factors in the South African adult population", BMC Obes, 2, pp.42~ (2015)
- Ng M, "Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013", Lancet, 384, pp.766~781 (2014)
- Papaetis GS, "Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns", Arch Med Sci, 11, pp.463~482 (2015)
- Kim SJ, "A protein profile of visceral adipose tissues linked to early pathogenesis of type 2 diabetes mellitus", Mol Cell Proteomics, 13, pp.811~822 (2014)
- Lehr S, "Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders", Proteomics Clin Appl, 6, pp.91~101 (2012)
- Kim JY, "Obesity-associated improvements in metabolic profile through expansion of adipose tissue", J Clin Invest, 117, pp.2621~2637 (2007)
- Coelho M, "Biochemistry of adipose tissue: an endocrine organ", Arch Med Sci, 9, pp.191~200 (2013)
- Booth A, "Adipose tissue: an endocrine organ playing a role in metabolic regulation", Horm Mol Biol Clin Investig (2016)
- Xita N, "Adiponectin in diabetes mellitus", Curr Med Chem, 19, pp.5451~5458 (2012)
- Ruan H, "Adiponectin signaling and function in insulin target tissues", J Mol Cell Biol (2016)
- Maury E, "Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome", Mol Cell Endocrinol, 314, pp.1~16 (2010)
- Coles CA, "Adipokines in Healthy Skeletal Muscle and Metabolic Disease", Adv Exp Med Biol, 900, pp.133~160 (2016)
- Hojlund K, "Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance", Dan Med J, 61, pp.B4890~ (2014)
- Coughlan KA, "AMPK activation: a therapeutic target for type 2 diabetes?", Diabetes Metab Syndr Obes, 7, pp.241~253 (2014)
- Ruderman NB, "AMPK, insulin resistance, and the metabolic syndrome", J Clin Invest, 123, pp.2764~2772 (2013)
- Yamauchi T, "Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase", Nat Med, 8, pp.1288~1295 (2002)
- Steinberg GR, "Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling", Cell Metab, 4, pp.465~474 (2006)
- Koopmans SJ, "Considerations on pig models for appetite, metabolic syndrome and obese type 2 diabetes: From food intake to metabolic disease", Eur J Pharmacol, 759, pp.231~239 (2015)
- Chen H, "The susceptibility of three strains of Chinese minipigs to diet-induced type 2 diabetes mellitus", Lab Anim (NY), 38, pp.355~363 (2009)
- Antuna-Puente B, "Adipokines: the missing link between insulin resistance and obesity", Diabetes Metab, 34, pp.2~11 (2008)
- Bluher M, "Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?", Clin Sci (Lond), 130, pp.1603~1614 (2016)
- Barbosa-Cortes L, "Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country", BMC Cancer, 17, pp.125~ (2017)
- Henquin JC, "Dynamics of glucose-induced insulin secretion in normal human islets", Am J Physiol Endocrinol Metab, 309, pp.E640~E650 (2015)
- Rorsman P, "Insulin granule dynamics in pancreatic beta cells", Diabetologia, 46, pp.1029~1045 (2003)
- Dufrane D, "Nutrient control of insulin secretion in perifused adult pig islets", Diabetes Metab, 33, pp.430~438 (2007)
- Esfahani M, "Adiponectin: an adipokine with protective features against metabolic syndrome", Iran J Basic Med Sci, 18, pp.430~442 (2015)
- Miki Okada-Iwabu, "Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity", Diabetes and Metabolism Journal, 39(5), pp.363~372 (2015), 대한당뇨병학회[DOI]
- Sarvas JL, "The IL-6 Paradox: Context Dependent Interplay of SOCS3 and AMPK", J Diabetes Metab, (Suppl 13) (2013)
- Perry RJ, "Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes", Cell, 160, pp.745~758 (2015)
- Fernandez-Real JM, "Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women", J Clin Endocrinol Metab, 86, pp.1154~1159 (2001)
- Carey AL, "Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase", Diabetes, 55, pp.2688~2697 (2006)
- Barnes KM, "Role of resistin in insulin sensitivity in rodents and humans", Curr Protein Pept Sci, 10, pp.96~107 (2009)
- Huang X, "Resistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans", J Endocrinol Invest, 39, pp.607~615 (2016)
- Ghosh S, "The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications", Gene, 305, pp.27~34 (2003)
- Nogueiras R, "Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner", FEBS Lett, 548, pp.21~27 (2003)
- Kusminski CM, "Role of resistin in obesity, insulin resistance and Type II diabetes", Clin Sci (Lond), 109, pp.243~256 (2005)
- Lee JH, "Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia", Am J Physiol Endocrinol Metab, 288, pp.E625~E632 (2005)
- Yannakoulia M, "Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans", J Clin Endocrinol Metab, 88, pp.1730~1736 (2003)
- Mohamed-Ali V, "Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo", Am J Physiol, 277, pp.E971~E975 (1999)
- Wascher TC, "Chronic TNF-alpha neutralization does not improve insulin resistance or endothelial function in 'healthy' men with metabolic syndrome", Mol Med, 17, pp.189~193 (2011)